Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Lack of efficacy in treating condyloma acuminata and preventing recurrences with the recombinant quadrivalent human papillomavirus vaccine in a case series of immunocompetent patients.

Kreuter A, Wieland U.

J Am Acad Dermatol. 2013 Jan;68(1):179-80. doi: 10.1016/j.jaad.2011.11.970. No abstract available.

PMID:
23244376
2.

[Advances in human papillomavirus therapeutic vaccine].

Liu B, Zhao QZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):685-90. Review. Chinese.

3.

An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.

Forcier M, Musacchio N.

Dermatol Ther. 2010 Sep-Oct;23(5):458-76. doi: 10.1111/j.1529-8019.2010.01350.x. Review.

PMID:
20868401
4.

The prophylactic role for the human papillomavirus quadrivalent vaccine in males.

Yancey AM, Pitlick JM, Forinash AB.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1314-8. doi: 10.1345/aph.1P017. Epub 2010 May 25. Review.

PMID:
20501891
5.

A quadrivalent vaccine for human papillomavirus.

Brown C, Gaston K.

Drugs Today (Barc). 2006 Nov;42(11):703-9. Review.

PMID:
17171189
6.

Vaccines for human papillomavirus infection: a critical analysis.

Nath AK, Thappa DM.

Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):245-53; quiz 254. doi: 10.4103/0378-6323.51240. Review.

7.

Human papillomavirus, genital warts, and vaccines.

Hsueh PR.

J Microbiol Immunol Infect. 2009 Apr;42(2):101-6. Review.

PMID:
19597640
8.

Impact of prophylactic human papillomavirus vaccines on dermatology and venereology.

Gross G.

G Ital Dermatol Venereol. 2008 Aug;143(4):259-65. Review.

PMID:
18833082
9.

The pediatrician's role in preventing cervical cancer.

Blatter MM, Monk BJ.

Clin Pediatr (Phila). 2008 Sep;47(7):627-38. doi: 10.1177/0009922808315219. Review. No abstract available.

PMID:
18698095
10.

Prophylactic HPV vaccines: new interventions for cancer control.

Barr E, Sings HL.

Vaccine. 2008 Nov 18;26(49):6244-57. doi: 10.1016/j.vaccine.2008.07.056. Epub 2008 Aug 9. Review.

PMID:
18694795
11.

Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine.

Ault KA.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):809-17. Review.

PMID:
14719852
12.

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

Goldstone SE, Vuocolo S.

Expert Rev Vaccines. 2012 Apr;11(4):395-406. doi: 10.1586/erv.12.20. Review.

PMID:
22551023
13.

Getting to know human papillomavirus (HPV) and the HPV vaccines.

Smith GD, Travis L.

J Am Osteopath Assoc. 2011 Mar;111(3 Suppl 2):S29-34. Review.

PMID:
21415377
14.

"Seborrheic keratoses" that contain human papillomavirus are condylomata acuminata.

Li J, Ackerman AB.

Am J Dermatopathol. 1994 Aug;16(4):398-405; discussion 406-8. Review.

PMID:
7978069
15.

Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil).

Siddiqui MA, Perry CM.

Drugs. 2006;66(9):1263-71; discussion 1272-3. Review.

PMID:
16827602
16.

HPV vaccine update: new indications and controversies.

Mendoza N, Hernandez PO, Tyring SK.

Skin Therapy Lett. 2011 Sep;16(8):1-3. Review.

17.

Human papillomavirus quadrivalent vaccine: a look behind the numbers.

Flaherty DK, Alkhateeb FM.

Ann Pharmacother. 2009 Apr;43(4):740-4. doi: 10.1345/aph.1L483. Epub 2009 Mar 10. Review.

PMID:
19276314
18.

Noncervical human papillomavirus genital infections.

Mayeaux EJ Jr, Harper MB, Barksdale W, Pope JB.

Am Fam Physician. 1995 Sep 15;52(4):1137-46, 1149-50. Review.

PMID:
7668205

Supplemental Content

Support Center